Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
置換キサンチン誘導体
Document Type and Number:
Japanese Patent JP5292413
Kind Code:
B2
Abstract:
A pharmaceutical composition comprising: a. an effective amount of a compound of Formula B: or a pharmaceutically acceptable salt thereof; b. a second therapeutic agent selected from insulin or insulin analogues, glucagon-like-peptide-1 (GLP-1) receptor agonists, sulfonylurea agents, biguanide agents, alpha-glucosidase inhibitors, PPAR agonists, meglitinide agents, dipeptidyl-peptidase (DPP) IV inhibitors, phosphodiesterase inhibitors, amylin agonists, CoEnzyme A inhibitors, and antiobesity agents; and c. a pharmaceutically acceptable car.

Inventors:
Toon Roger Dee.
Ryu Julie F.
Herbson Scott El.
Application Number:
JP2010548745A
Publication Date:
September 18, 2013
Filing Date:
February 27, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Concert Pharmaceuticals Incorporated
International Classes:
C07D473/10; A61K31/522; A61P1/16; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P7/02; A61P9/10; A61P9/12; A61P13/02; A61P13/12; A61P19/06; A61P27/02
Domestic Patent References:
JP9510717A
JP2009511481A
Other References:
KUSHNER DJ,PHARMACOLOGICAL USES AND PERSPECTIVES OF HEAVY WATER AND DEUTERATED COMPOUNDS,CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY,カナダ,1999年 2月 1日,V77 N2,P79-88
FOSTER A B,DEUTERIUM ISOTOPE EFFECTS IN THE METABOLISM OF DRUGS AND XENOBIOTICS: IMPLICATIONS FOR DRUG DESIGN,ADVANCED IN DRUG RESEARCH,英国,ACADEMIC PRESS,1985年 1月 1日,V14,P1-40
Journal of Pharmacology and Experimental Therapeutics,1997年,Vol.284, No.1,pp.337-345
Chirality,2002年,Vol.14, No.8,pp.643-652
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto



 
Previous Patent: JPS5292412

Next Patent: 給湯機